Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis> | Crystals of Lem4 (6 -218) D25N and Lem4 (6 -218) S96A were obtained in 0.1 M Bis -Tris pH 6.5, 0.2 M magnesium acetate tetrahydrate, 0. 6 M NaCl and 2 2 % (w/v) PEG 3350. In order to obtain the complex with the substrate (phosphate) , the phosphorylated peptide derived from CSF1R (synthesized by Genscript (Piscataway, NJ, USA)) was added to the drop at a final concentration of 1 -2 mM | Get A Quote |
is a Gram-negative pathogenic bacterium that causes severe pneumonia in humans. It establishes a replicative niche called -containing vacuole (LCV) that allows bacteria to survive and replicate inside pulmonary macrophages. To hijack host cell defense systems, injects over 300 effector proteins into the host cell cytosol. The Lem4 effector (lpg1101) consists of two domains: an N-terminal haloacid dehalogenase (HAD) domain with unknown function and a C-terminal phosphatidylinositol 4-phosphate-binding domain that anchors Lem4 to the membrane of early LCVs. Herein, we demonstrate that the HAD domain (Lem4-N) is structurally similar to mouse MDP-1 phosphatase and displays phosphotyrosine phosphatase activity.... More